These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 18942475

  • 21. Microvascular function in human essential hypertension.
    Shore AC, Tooke JE.
    J Hypertens; 1994 Jul; 12(7):717-28. PubMed ID: 7963499
    [No Abstract] [Full Text] [Related]

  • 22. Vascular remodelling in hypertension.
    Mulvany MJ.
    Eur Heart J; 1993 Jul; 14 Suppl C():2-4. PubMed ID: 8365424
    [Abstract] [Full Text] [Related]

  • 23. [Clinico-instrumental diagnosis of changes in the vascular wall in hypertension].
    Kutsyi SV.
    Vrach Delo; 1976 Sep; (9):53-6. PubMed ID: 982980
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [The dermo-hypodermal vascular changes in hypertensive patients. Studies with optic and electron microscopes].
    Durand M, Durand A, Hatt PY.
    Pathol Biol; 1967 Sep; 15(11):573-86. PubMed ID: 4862319
    [No Abstract] [Full Text] [Related]

  • 26. Autocrine-paracrine factors and vascular remodeling in hypertension.
    Gibbons GH.
    Curr Opin Nephrol Hypertens; 1993 Mar; 2(2):291-8. PubMed ID: 7922189
    [Abstract] [Full Text] [Related]

  • 27. Hypertension; its effect on the vascular system.
    MOYER JH.
    Hahnemannian; 1959 Mar; 94(1):1-9. PubMed ID: 13640395
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Diurnal variation of endothelial function and arterial stiffness in hypertension.
    Kollias GE, Stamatelopoulos KS, Papaioannou TG, Zakopoulos NA, Alevizaki M, Alexopoulos GP, Kontoyannis DA, Karga H, Koroboki E, Lekakis JP, Papamichael CM.
    J Hum Hypertens; 2009 Sep; 23(9):597-604. PubMed ID: 19242493
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Therapeutic regression of vascular structure in essential hypertension: principles and benefits. Copenhagen, November 7th, 1986. Proceedings.
    J Clin Hypertens; 1987 Sep; 3(3):311-76. PubMed ID: 3668591
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Vascular remodeling and its role in the pathogenesis of ascites in fast growing commercial broilers.
    Nain S, Wojnarowicz C, Laarveld B, Olkowski AA.
    Res Vet Sci; 2009 Jun; 86(3):479-84. PubMed ID: 18947843
    [Abstract] [Full Text] [Related]

  • 34. In vitro characteristics of vessels from patients with essential hypertension.
    Aalkjaer C, Heagerty AM, Mulvany MJ.
    J Clin Hypertens; 1987 Sep; 3(3):317-22. PubMed ID: 3668592
    [No Abstract] [Full Text] [Related]

  • 35. [Blood pressure components and target organ damage].
    Schillaci G, Reboldi G, Vaudo G.
    Ital Heart J Suppl; 2001 Apr; 2(4):363-8. PubMed ID: 19397008
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. T cells and blood vessels: costimulation turns up the pressure.
    Bu DX, Lichtman AH.
    Circulation; 2010 Dec 14; 122(24):2495-8. PubMed ID: 21126974
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension.
    Peled N, Shitrit D, Fox BD, Shlomi D, Amital A, Bendayan D, Kramer MR.
    J Rheumatol; 2009 May 14; 36(5):970-5. PubMed ID: 19369472
    [Abstract] [Full Text] [Related]

  • 40. [Severity of familial hyperkalemic hypertension caused by CUL-3 mutations: a story about kidneys and blood vessels].
    Rafael C, Hadchouel J.
    Med Sci (Paris); 2020 May 14; 36(5):455-458. PubMed ID: 32452365
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.